Kilian Kelly

Kilian Kelly

Chief Executive Officer chez CYNATA THERAPEUTICS LIMITED

Fortune : 65 142 $ au 31/03/2024

Commercial Services
Health Technology
Consumer Services

Profil

Kilian Kelly is currently the Chief Executive Officer & Managing Director at Cynata Therapeutics Ltd.
He is also a Member of the Regulatory Affairs Professionals Society, the Royal Pharmaceutical Society of Great Britain, the International Society for Cellular Therapy, the Australian Institute of Co. Directors, and The Organisation for Professionals in Regulatory Affairs Ltd.
In the past, Dr. Kelly held the position of Senior Director-Drug Development at Aviragen Therapeutics, Inc. and Vice President-Regulatory & Clinical at Mesoblast Ltd.
Dr. Kelly obtained a doctorate degree from the University of Strathclyde and a graduate degree from The Robert Gordon University.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
30/06/2023 525 508 ( 0,29% ) 65 142 $ 31/03/2024

Postes actifs de Kilian Kelly

SociétésPosteDébut
CYNATA THERAPEUTICS LIMITED Chief Executive Officer 01/07/2023
Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -
Tous les postes actifs de Kilian Kelly

Anciens postes connus de Kilian Kelly

SociétésPosteFin
MESOBLAST LIMITED Chief Tech/Sci/R&D Officer -
Corporate Officer/Principal -
Voir l'expérience en détail de Kilian Kelly

Formation de Kilian Kelly

University of Strathclyde Doctorate Degree
The Robert Gordon University Graduate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Kilian Kelly

Relations

100 +

Relations au 1er degré

10

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées2
MESOBLAST LIMITED

Health Technology

CYNATA THERAPEUTICS LIMITED

Health Technology

Entreprise privées6

Commercial Services

Commercial Services

Commercial Services

Commercial Services

Commercial Services

Health Technology

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Kilian Kelly